Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT02634216
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be 10 - 60 yrs. of age
* Type 1 Diabetes using Continuous Glucose Monitoring (CGM) for at least the last 3 months
* Less than 10% variation in prescribed long acting dosages in the previous 3 months
Exclusion Criteria:
* Individuals who are deemed unable to understand the procedures, risks and benefits of the study, i.e. informed consent will be excluded from the study
* Females who are pregnant
* Individuals who are therapeutically immuno-compromised
* Prisoners
* Anyone with a known allergy to amla fruit
* Current use of any of the following medications will result in exclusion:
* Steroids (Prednisone, etc.)
* Immunosuppressants
* Accutane (last 6 months)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
60 Years
Study:
NCT02634216
Study Brief:
Protocol Section:
NCT02634216